Skip to main content

Advertisement

Log in

A cross-sectional study on late taste disorders in survivors of allogeneic hematopoietic cell transplantation

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Taste disorders are one of the most common complications in patients undergoing allogeneic hematopoietic cell transplantation (HCT). They persist in some patients as a late complication 3 months or more after HCT. Therefore, we conducted a cross-sectional study to evaluate the prevalence and predictive factors of late taste disorders, with the help of a self-reporting and closed-ended questionnaire, which was distributed among 91 patients in our institute. The median age at this study was 50 (range, 25–69) years. The median follow-up period was 54 (range, 3–234) months after HCT. Taste disorders were observed in 43 patients (47%). The most frequent form of late taste disorders was reduced appetite in 18 patients (20%). The most frequent form of decline of basic taste was umami, which was observed in 12 patients (13%). Almost all taste disorders were mild in their severity. Multivariate logistic regression analyses showed that the duration of less than 1 year post HCT and the presence of oral chronic graft-versus-host disease are important risk factors for late taste disorders in survivors of HCT. These data suggested that taste disorders usually return to normal levels more than a year after HCT in most recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KE, Elting LS et al (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18:1081–1087

    Article  PubMed  Google Scholar 

  2. Gamper EM, Zabernigg A, Wintner LM, Giesinger JM, Oberguggenberger A, Kemmler G et al (2012) Coming to your senses: detecting taste and smell alterations in chemotherapy patients. A systematic review. J Pain Symptom Manag 44:880–895

    Article  Google Scholar 

  3. Ruo Redda MG, Allis S (2006) Radiotherapy-induced taste impairment. Cancer Treat Rev 32:541–547

    Article  PubMed  Google Scholar 

  4. Boer CC, Correa ME, Miranda EC, de Souza CA (2010) Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT. Bone Marrow Transplant 45:705–711

    Article  CAS  PubMed  Google Scholar 

  5. Marinone MG, Rizzoni D, Ferremi P, Rossi G, Izzi T, Brusotti C (1991) Late taste disorders in bone marrow transplantation: clinical evaluation with taste solutions in autologous and allogeneic bone marrow recipients. Haematologica 76:519–522

    CAS  PubMed  Google Scholar 

  6. Mattsson T, Arvidson K, Heimdahl A, Ljungman P, Dahllof G, Ringdén O (1992) Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol Med 21:33–37

    Article  CAS  PubMed  Google Scholar 

  7. Majorana A, Amadori F, Bardellini E, Campus G, Conti G, Strohmenger L et al (2015) Taste dysfunction in patients undergoing hematopoietic stem cell transplantation: clinical evaluation in children. Pediatr Transplant 19:571–575

    Article  PubMed  Google Scholar 

  8. Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P (2002) Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30:785–792

    Article  CAS  PubMed  Google Scholar 

  9. Kano T, Kanda K (2013) Development and validation of a chemotherapy-induced taste alteration scale. Oncol Nurs Forum 40:E79–E85

    Article  PubMed  Google Scholar 

  10. Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M et al (2009) Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 15:367–369

    Article  PubMed  PubMed Central  Google Scholar 

  11. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11:945–956

    Article  PubMed  Google Scholar 

  12. Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48:452–458

    Article  CAS  PubMed  Google Scholar 

  13. Shi HB, Masuda M, Umezaki T, Kuratomi Y, Kumamoto Y, Yamamoto T et al (2004) Irradiation impairment of umami taste in patients with head and neck cancer. Auris Nasus Larynx 31:401–406

    Article  PubMed  Google Scholar 

  14. Turcott JG, Juárez-Hernández E, De la Torre-Vallejo M, Sánchez-Lara K, Luvian-Morales J, Arrieta O (2016) Changes in the detection and recognition thresholds of three basic tastes in lung cancer patients receiving cisplatin and paclitaxel and its association with nutritional and quality of life parameters. Nutr Cancer 68:241–249

    Article  CAS  PubMed  Google Scholar 

  15. Tsutsumi R, Goda M, Fujimoto C, Kanno K, Nobe M, Kitamura Y et al (2016) Effects of chemotherapy on gene expression of lingual taste receptors in patients with head and neck cancer. Laryngoscope 126:E103–E109

    Article  CAS  PubMed  Google Scholar 

  16. Lilleby K, Garcia P, Gooley T, McDonnnell P, Taber R, Holmberg L et al (2006) A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 37:1031–1035

    Article  CAS  PubMed  Google Scholar 

  17. Marchesi F, Tendas A, Giannarelli D, Viggiani C, Gumenyuk S, Renzi D et al (2017) Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study. Bone Marrow Transplant 52:154–156

    Article  CAS  PubMed  Google Scholar 

  18. Okada N, Hanafusa T, Abe S, Sato C, Nakamura T, Teraoka K et al (2016) Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention. Support Care Cancer 24:3979–3985

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank all of the physicians and staff at the hospital for their help in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takaaki Konuma.

Ethics declarations

Conflict of interest

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sato, T., Konuma, T., Miwa, Y. et al. A cross-sectional study on late taste disorders in survivors of allogeneic hematopoietic cell transplantation. Ann Hematol 96, 1841–1847 (2017). https://doi.org/10.1007/s00277-017-3087-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-3087-6

Keywords

Navigation